» Articles » PMID: 35392227

PH-Responsive Polymer Nanomaterials for Tumor Therapy

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Apr 8
PMID 35392227
Authors
Affiliations
Soon will be listed here.
Abstract

The complexity of the tumor microenvironment presents significant challenges to cancer therapy, while providing opportunities for targeted drug delivery. Using characteristic signals of the tumor microenvironment, various stimuli-responsive drug delivery systems can be constructed for targeted drug delivery to tumor sites. Among these, the pH is frequently utilized, owing to the pH of the tumor microenvironment being lower than that of blood and healthy tissues. pH-responsive polymer carriers can improve the efficiency of drug delivery , allow targeted drug delivery, and reduce adverse drug reactions, enabling multifunctional and personalized treatment. pH-responsive polymers have gained increasing interest due to their advantageous properties and potential for applicability in tumor therapy. In this review, recent advances in, and common applications of, pH-responsive polymer nanomaterials for drug delivery in cancer therapy are summarized, with a focus on the different types of pH-responsive polymers. Moreover, the challenges and future applications in this field are prospected.

Citing Articles

Maytansinoids in cancer therapy: advancements in antibody-drug conjugates and nanotechnology-enhanced drug delivery systems.

Perra M, Castangia I, Aroffu M, Fulgheri F, Abi-Rached R, Manca M Discov Oncol. 2025; 16(1):73.

PMID: 39838217 PMC: 11751265. DOI: 10.1007/s12672-025-01820-z.


Review and Future Perspectives of Stimuli-Responsive Bridged Polysilsesquioxanes in Controlled Release Applications.

Zhang X, Zhang H, Liu X, Wang J, Li S, Gao P Polymers (Basel). 2024; 16(22).

PMID: 39599255 PMC: 11598018. DOI: 10.3390/polym16223163.


Demystifying the management of cancer through smart nano-biomedicine via regulation of reactive oxygen species.

Mishra A, Kumar R, Harilal S, Nigam M, Datta D, Singh S Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):497-532.

PMID: 39480523 DOI: 10.1007/s00210-024-03469-x.


Engineering Stimuli-Responsive Materials for Precision Medicine.

Zheng R, Yu C, Yao D, Cai M, Zhang L, Ye F Small. 2024; 21(1):e2406439.

PMID: 39444066 PMC: 11707583. DOI: 10.1002/smll.202406439.


Integrating Computational Design and Experimental Approaches for Next-Generation Biologics.

Son A, Park J, Kim W, Lee W, Yoon Y, Ji J Biomolecules. 2024; 14(9).

PMID: 39334841 PMC: 11430650. DOI: 10.3390/biom14091073.


References
1.
He L, Fullenkamp D, Rivera J, Messersmith P . pH responsive self-healing hydrogels formed by boronate-catechol complexation. Chem Commun (Camb). 2011; 47(26):7497-9. PMC: 4526106. DOI: 10.1039/c1cc11928a. View

2.
He C, Hu Y, Yin L, Tang C, Yin C . Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010; 31(13):3657-66. DOI: 10.1016/j.biomaterials.2010.01.065. View

3.
Wang Z, Chen C, Zhang Q, Gao M, Zhang J, Kong D . Tuning the architecture of polymeric conjugate to mediate intracellular delivery of pleiotropic curcumin. Eur J Pharm Biopharm. 2014; 90:53-62. DOI: 10.1016/j.ejpb.2014.11.002. View

4.
Ji T, Zhao Y, Ding Y, Nie G . Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications. Adv Mater. 2013; 25(26):3508-25. DOI: 10.1002/adma.201300299. View

5.
Gopal V, Dubashi B, Kayal S, Penumadu P, Rajaram M, Karunanithi G . Challenges in the Management of Lung Cancer: Real-World Experience from a Tertiary Center in South India. South Asian J Cancer. 2021; 10(3):175-182. PMC: 8687871. DOI: 10.1055/s-0041-1733312. View